These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 24159668)

  • 1. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2013 Oct; 88(42):449-63. PubMed ID: 24159668
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2014 Mar; 89(11):105-15. PubMed ID: 24707515
    [No Abstract]   [Full Text] [Related]  

  • 3. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2013 Mar; 88(11):117-25. PubMed ID: 23544238
    [No Abstract]   [Full Text] [Related]  

  • 4. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2012 Oct; 87(42):401-12. PubMed ID: 23113329
    [No Abstract]   [Full Text] [Related]  

  • 5. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2012 Mar; 87(11):97-108. PubMed ID: 22462204
    [No Abstract]   [Full Text] [Related]  

  • 6. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2011 Oct; 86(43):469-80. PubMed ID: 22046595
    [No Abstract]   [Full Text] [Related]  

  • 7. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2015 Mar; 90(12):109-20. PubMed ID: 25796641
    [No Abstract]   [Full Text] [Related]  

  • 8. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2015 Oct; 90(42):561-71. PubMed ID: 26477059
    [No Abstract]   [Full Text] [Related]  

  • 9. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2018 Mar; 93(12):142-52. PubMed ID: 29569430
    [No Abstract]   [Full Text] [Related]  

  • 10. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2014 Oct; 89(42):457-64. PubMed ID: 25337626
    [No Abstract]   [Full Text] [Related]  

  • 11. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2016 Oct; 91(42):485-99. PubMed ID: 27766828
    [No Abstract]   [Full Text] [Related]  

  • 12. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses for development of candidate vaccines viruses for pandemic preparedness - February 2011.
    Wkly Epidemiol Rec; 2011 Mar; 86(11):93-100. PubMed ID: 21395189
    [No Abstract]   [Full Text] [Related]  

  • 13. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2017 Mar; 92(12):129-44. PubMed ID: 28337863
    [No Abstract]   [Full Text] [Related]  

  • 14. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2016 Mar; 91(11):133-43. PubMed ID: 26995804
    [No Abstract]   [Full Text] [Related]  

  • 15. Preparing for a potential A(H7N9) pandemic: lessons from the deployment of A(H1N1) pandemic vaccines.
    Nguyen-Van-Tam JS; Sellwood C
    Expert Rev Vaccines; 2013 Aug; 12(8):825-8. PubMed ID: 23984955
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of highly pathogenic avian influenza A(H5N1) gain-of-function studies for molecular-based surveillance and pandemic preparedness.
    Davis CT; Chen LM; Pappas C; Stevens J; Tumpey TM; Gubareva LV; Katz JM; Villanueva JM; Donis RO; Cox NJ
    mBio; 2014 Dec; 5(6):. PubMed ID: 25505125
    [No Abstract]   [Full Text] [Related]  

  • 17. Antigenic and genetic characteristics of influenza A(H5N1) viruses and candidate vaccine viruses developed for potential use in human vaccines.
    Wkly Epidemiol Rec; 2009 Oct; 84(41):432-6. PubMed ID: 19817020
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of live attenuated influenza vaccines against pandemic influenza strains.
    Coelingh KL; Luke CJ; Jin H; Talaat KR
    Expert Rev Vaccines; 2014 Jul; 13(7):855-71. PubMed ID: 24867587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2017 Oct; 92(42):633-47. PubMed ID: 29052410
    [No Abstract]   [Full Text] [Related]  

  • 20. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines - February 2010.
    Wkly Epidemiol Rec; 2010 Mar; 85(11):100-7. PubMed ID: 20229648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.